UNC0224 - CAS 1197196-48-7
Catalog number: 1197196-48-7
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C26H43N7O2
Molecular Weight:
485.67
COA:
Inquire
Targets:
HMTase
Description:
The methylation of lysine residues on histones plays a central role in determining euchromatin structure and gene expression. The histone methyltransferase (HMTase) G9a can mono- or dimethylate lysine 9 on histone 3 (H3), contributing to early embryogenesis, genomic imprinting, and lymphocyte development. UNC0224 is a potent and selective G9a HMTase inhibitor, exhibiting an IC50 value of 15 nM. Isothermal titration calorimetry revealed UNC0224 binds to G9a with a Kd value of 29 nM. UNC0224 also inhibits GLP, a closely-related H3K9 HMTase, with assay-dependent IC50 values of 20-58 nM, but is more than 1,000-fold selective against SET7/9 (a H3K4 HMTase) and SET8 (a H4K20 HMTase).
Purity:
>98%
Synonyms:
UNC0224; UNC-0224; UNC 0224; 7-[3-(Dimethylamino)propoxy]-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6-methoxy-N-(1-methyl-4-piperidinyl)-4-quinazolinamine
MSDS:
Inquire
InChIKey:
XIVUGRBSBIXXJE-UHFFFAOYSA-N
InChI:
InChI=1S/C26H43N7O2/c1-30(2)10-7-17-35-24-19-22-21(18-23(24)34-5)25(27-20-8-13-32(4)14-9-20)29-26(28-22)33-12-6-11-31(3)15-16-33/h18-20H,6-17H2,1-5H3,(H,27,28,29)
Canonical SMILES:
CN1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)NC4CCN(CC4)C)OC)OCCCN(C)C
1.Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.
Liu F;Chen X;Allali-Hassani A;Quinn AM;Wigle TJ;Wasney GA;Dong A;Senisterra G;Chau I;Siarheyeva A;Norris JL;Kireev DB;Jadhav A;Herold JM;Janzen WP;Arrowsmith CH;Frye SV;Brown PJ;Simeonov A;Vedadi M;Jin J J Med Chem. 2010 Aug 12;53(15):5844-57. doi: 10.1021/jm100478y.
Protein lysine methyltransferase G9a, which catalyzes methylation of lysine 9 of histone H3 (H3K9) and lysine 373 (K373) of p53, is overexpressed in human cancers. Genetic knockdown of G9a inhibits cancer cell growth, and the dimethylation of p53 K373 results in the inactivation of p53. Initial SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template represented by 3a (BIX01294), a selective small molecule inhibitor of G9a and GLP, led to the discovery of 10 (UNC0224) as a potent G9a inhibitor with excellent selectivity. A high resolution X-ray crystal structure of the G9a-10 complex, the first cocrystal structure of G9a with a small molecule inhibitor, was obtained. On the basis of the structural insights revealed by this cocrystal structure, optimization of the 7-dimethylaminopropoxy side chain of 10 resulted in the discovery of 29 (UNC0321) (Morrison K(i) = 63 pM), which is the first G9a inhibitor with picomolar potency and the most potent G9a inhibitor to date.
2.Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
Liu F;Chen X;Allali-Hassani A;Quinn AM;Wasney GA;Dong A;Barsyte D;Kozieradzki I;Senisterra G;Chau I;Siarheyeva A;Kireev DB;Jadhav A;Herold JM;Frye SV;Arrowsmith CH;Brown PJ;Simeonov A;Vedadi M;Jin J J Med Chem. 2009 Dec 24;52(24):7950-3. doi: 10.1021/jm901543m.
SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template led to the discovery of 8 (UNC0224) as a potent and selective G9a inhibitor. A high resolution X-ray crystal structure of the G9a-8 complex, the first cocrystal structure of G9a with a small molecule inhibitor, was obtained. The cocrystal structure validated our binding hypothesis and will enable structure-based design of novel inhibitors. 8 is a useful tool for investigating the biology of G9a and its roles in chromatin remodeling.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HMTase Products


CAS 1271738-59-0 MI-3

MI-3
(CAS: 1271738-59-0)

MI-3 (Menin-MLL Inhibitor) is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.

CAS 935693-62-2 BIX-01294

BIX-01294
(CAS: 935693-62-2)

BIX-01294, a diazepin-quinazolinamine derivative, is a selective inhibitor of G9a histone methyl transferase (G9a HMTase) that impairs G9a HMTase and generation...

CAS 1380316-03-9 EPZ004777 hydrochloride

EPZ004777 hydrochloride
(CAS: 1380316-03-9)

EPZ004777 selectively inhibits cellular H3K79 methylation and inhibits expression of key MLL fusion target genes. Following DOT1L inhibition, EPZ004777 selectiv...

CAS 1158279-20-9 HLCL-61 hydrochloride

HLCL-61 hydrochloride
(CAS: 1158279-20-9)

The hydrochloride salt form of HLCL-61, an effective inhibitor of PRMT5, could probably useful in the treatment of acute myeloid leukemia.

CAS 1857417-13-0 MI-503

MI-503
(CAS: 1857417-13-0)

MI-503 is a potent, selective and orally bioavailable Menin-MLL inhibitor (IC50= 14.7 nM). It is used in the pharmacological inhibition of menin-MLL interaction...

CAS 1417329-24-8 MM-102

MM-102
(CAS: 1417329-24-8)

MM-102, as a MLL1 mimetic, shows high binding affinities to WDR5 with IC50 of 2.9 nM and Ki of < 1 nM.

CAS 1020399-49-8 CARM1-IN-1

CARM1-IN-1
(CAS: 1020399-49-8)

CARM1-IN-1 is a potent and specific CARM1(Coactivator-associated arginine methyltransferase 1) inhibitor with IC50 of 8.6 μM and shows very low activity against...

CAS 1616391-87-7 EPZ015866

EPZ015866
(CAS: 1616391-87-7)

EPZ015866,also called as GSK591, is a chemical probe for PRMT5 which has a role in diverse cellular processes including tumorigenesis. It exhibits excellent sel...

Chemical Structure

CAS 1197196-48-7 UNC0224

Quick Inquiry

Verification code

Featured Items